Los puntos clave no están disponibles para este artículo en este momento.
This article reviews the risks of osteoporosis and osteonecrosis associated with glucocorticoid use, which are present even in the absence of low bone mineral density, and discusses strategies to reduce the risk of fractures and the data to support the strategies.
Robert S. Weinstein (Wed,) studied this question.